Work

Longer-term efficacy and safety of zodasiran in patients with mixed hyperlipidaemia

Year: 2026

Type: article

Study design: Clinical Trial

Source: European Journal of Preventive Cardiology

DOI: 10.1093/eurjpc/zwag376

Authors: Robert S Rosenson, Daniel Gaudet, Christie M Ballantyne, Stephen J Nicholls, Kathryn J Lucas, Nicholas J Leeper, Rong Zhou, Lalitha Aiyer, Jennifer Hellawell, Gerald F Watts

Institutions: Icahn School of Medicine at Mount Sinai, Université de Montréal, Baylor College of Medicine, Monash University, Lucas Research, Stanford Medicine, Stanford Cardiovascular Institute, Stanford University, Arrowhead Pharmaceuticals (United States), The University of Western Australia, Royal Perth Hospital

Language: English

Topic: Lipid metabolism and disorders

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Arrowhead Pharmaceuticals

OpenAlex ID: W7170703574

FWCI:

Cites: 42

Cited by:

Related to: